Citation: | HUANG Yu, ZHANG Yinsheng. Advances in the synthetic methods of bicyclo[1.1.1]pentane derivatives[J]. Journal of China Pharmaceutical University, 2022, 53(2): 137-145. DOI: 10.11665/j.issn.1000-5048.20220202 |
[1] |
pentane (BCP) in drug design [J]. J China Pharm Univ (中国药科大学学报),2022,53(1):1-9.
|
[2] |
Bauer MR,di Fruscia P,Lucas SCC,et al. Put a ring on it:application of small aliphatic rings in medicinal chemistry[J]. RSC Med Chem,2021,12(4):448-471.
|
[3] |
Wiberg KB,Connor DS,Lampman GM. The reaction of 3-bromocyclobutane-1-methyl bromide with sodium:bicyclo [1.1.1] pentane[J]. Tetrahedron Lett,1964,5(10):531-534.
|
[4] |
Wiberg KB,Lampman GM,Ciula RP,et al. Bicyclo [1.1.0]butane[J]. Tetrahedron,1965,21(10):2749-2769.
|
[5] |
Applequist DE,Renken TL,Wheeler JW. Polar substituent effects in 1,3-disubstituted bicyclo [1.1.1] pentanes[J]. J Org Chem,1982,47(25):4985-4995.
|
[6] |
Ma XS,Sloman DL,Han YX,et al. A selective synthesis of 2,2-difluorobicyclo [1.1.1] pentane analogues:"BCP-F 2"[J]. Org Lett,2019,21(18):7199-7203.
|
[7] |
Bychek RM,Hutskalova V,Bas YP,et al. Difluoro-substituted bicyclo[1.1.1]pentanes for medicinal chemistry:design,synthesis,and characterization[J]. J Org Chem,2019,84(23):15106-15117.
|
[8] |
Gianatassio R,Lopchuk JM,Wang J,et al. Organic chemistry. strain-release amination[J]. Science,2016,351(6270):241-246.
|
[9] |
Sterling AJ,Dürr AB,Smith RC,et al. Rationalizing the diverse reactivity of [1.1.1] propellane through σ-π-delocalization[J]. Chem Sci,2020,11(19):4895-4903.
|
[10] |
Wiberg KB,Walker FH. [1.1.1]propellane[J]. J Am Chem Soc,1982,104(19):5239-5240.
|
[11] |
Semmler K,Szeimies G,Belzner J. Tetracyclo[5.1.0.01,6.02,7]octane,a [1.1.1] propellane derivative,and a new route to the parent hydrocarbon[J]. J Am Chem Soc,1985,107(22):6410-6411.
|
[12] |
Belzner J,Bunz U,Semmler K,et al. Concerning the synthesis of[1.1.1] propellane[J]. Chem Ber,1989,122(2):397-398.
|
[13] |
Caputo DFJ,Arroniz C,Dürr AB,et al. Synthesis and applications of highly functionalized 1-halo-3-substituted bicyclo[1.1.1] pentanes[J]. Chem Sci,2018,9(23):5295-5300.
|
[14] |
Nugent J,Arroniz C,Shire BR,et al. A general route to bicyclo[1.1.1] pentanes through photoredox catalysis[J]. ACS Catal,2019,9(10):9568-9574.
|
[15] |
Nugent J,Shire BR,Caputo DFJ,et al. Synthesis of all-carbon disubstituted bicyclo [1.1.1]pentanes by iron-catalyzed kumada cross-coupling[J]. Angew Chem Int Ed Engl,2020,59(29):11866-11870.
|
[16] |
Shin S,Lee S,Choi W,et al. Visible-light-induced 1,3-aminopyridylation of [1.1.1] propellane with N-aminopyridinium salts[J]. Angew Chem Int Ed,2021,60(14):7873-7879.
|
[17] |
Wong MLJ,Sterling AJ,Mousseau JJ,et al. Direct catalytic asymmetric synthesis of α-chiral bicyclo [1.1.1]pentanes[J]. Nat Commun,2021,12(1):1644.
|
[18] |
Kondo M,Kanazawa J,Ichikawa T,et al. Silaboration of [1.1.1]propellane:a storable feedstock for bicyclo[1.1.1]pentane derivatives[J]. Angew Chem Int Ed Engl,2020,59(5):1970-1974.
|
[19] |
Kanazawa J,Maeda K,Uchiyama M. Radical multicomponent carboamination of [1.1.1]propellane[J]. J Am Chem Soc,2017,139(49):17791-17794.
|
[20] |
Kim JH,Ruffoni A,Al-Faiyz YSS,et al. Divergent strain-release amino-functionalization of [1.1.1] propellane with electrophilic nitrogen-radicals[J]. Angew Chem Int Ed Engl,2020,59(21):8225-8231.
|
[21] |
Zhang XH,Smith RT,Le C,et al. Copper-mediated synthesis of drug-like bicyclopentanes[J]. Nature,2020,580(7802):220-226.
|
[22] |
Wiberg KB,Waddell ST. Reactions of [1.1.1] propellane[J]. J Am Chem Soc,1990,112(6):2194-2216.
|
[23] |
Della EW,Taylor DK,Tsanaktsidis J. Unusual bridgehead reactivity:formation of [1.1.1] propellane by 1,3-dehydrobromination of 1-bromobicyclo [1.1.1] pentane[J]. Tetrahedron Lett,1990,31(36):5219-5220.
|
[24] |
Bunz U,Szeimies G. Reduction of [1.1.1] propellane with lithium 4,4''-di-t-butylbiphenyl:bicyclo [1.1.1] pent-1,3-diyldilithium[J]. Tetrahedron Lett,1990,31(5):651-652.
|
[25] |
Messner M,Kozhushkov SI,de Meijere A. Nickel- and palladium-catalyzed cross-coupling reactions at the bridgehead of bicyclo[1.1.1]pentane derivatives — A convenient access to liquid crystalline compounds containing bicyclo [1.1.1] pentane moieties[J]. Eur J Org Chem,2000,2000(7):1137-1155.
|
[26] |
Makarov IS,Brocklehurst CE,Karaghiosoff K,et al. Synthesis of bicyclo [1.1.1] pentane bioisosteres of internal alkynes and para-disubstituted benzenes from [1.1.1] propellane[J]. Angew Chem Int Ed Engl,2017,56(41):12774-12777.
|
[27] |
Yu SJ,Jing CC,Noble A,et al. Iridium-catalyzed enantioselective synthesis of α-chiral bicyclo [1.1.1] pentanes by 1,3-difunctionalization of [1.1.1] propellane[J]. Org Lett,2020,22(14):5650-5655.
|
[28] |
Lopchuk JM,Fjelbye K,Kawamata Y,et al. Strain-release heteroatom functionalization:development,scope,and stereospecificity[J]. J Am Chem Soc,2017,139(8):3209-3226.
|
[29] |
Shelp RA,Walsh PJ. Synthesis of BCP benzylamines from 2-azaallyl anions and [1.1.1]propellane[J]. Angew Chem Int Ed Engl,2018,57(48):15857-15861.
|
[30] |
Shelp RA,Ciro A,Pu YG,et al. Strain-release 2-azaallyl anion addition/borylation of [1.1.1]propellane:synthesis and functionalization of benzylamine bicyclo[1.1.1]pentyl boronates[J]. Chem Sci,2021,12(20):7066-7072.
|
[31] |
Wiberg KB,McMurdie N. Formation and reactions of bicyclo[1.1.1]pentyl-1 cations[J]. J Am Chem Soc,1994,116(26):11990-11998.
|
[32] |
Garlets ZJ,Sanders JN,Malik H,et al. Enantioselective C-H functionalization of bicyclo[1.1.1]pentanes[J]. Nat Catal,2020,3(4):351-357.
|
[33] |
Zhao JX,Chang Y,Elleraas J,et al. 1,2-Difunctionalized Bicyclo[1.1.1]pentanes:long sought after bioisosteres for ortho/meta-substituted arenes[J]. ChemRxiv,2020.
|
[34] |
Ma XS,Han YX,Bennett DJ. Selective synthesis of 1-dialkylamino-2-alkylbicyclo-[1.1.1]pentanes[J]. Org Lett,2020,22(22):9133-9138.
|
[35] |
Yang YY,Tsien J,Hughes J,et al. Synthesis of multi-substituted bicycloalkyl boronates:an intramolecular coupling approach to alkyl bioisosteres[J]. ChemRxiv,2021.
|
[1] | YANG Qian, WANG Xiaojian. Research progress of sphingosine kinase 1 inhibitors[J]. Journal of China Pharmaceutical University, 2021, 52(6): 759-768. DOI: 10.11665/j.issn.1000-5048.20210615 |
[2] | LI Yin, GU Hongfeng, ZOU Yi, WANG Shuping, XU Yungen. Research progress of mono-(ADP-ribosyl) transferase family and their inhibitors in tumor therapy[J]. Journal of China Pharmaceutical University, 2021, 52(6): 643-652. DOI: 10.11665/j.issn.1000-5048.20210601 |
[3] | BU Hong, ZHOU Jinpei, ZHANG Huibin. Research progress of mitogen-activated protein kinase interacting kinases inhibitors in tumor immunotherapy[J]. Journal of China Pharmaceutical University, 2021, 52(4): 410-421. DOI: 10.11665/j.issn.1000-5048.20210403 |
[4] | FENG Yang, XU Xiao, MO Ran. Advances in lymphatic targeted drug delivery system for treatment of tumor metastasis[J]. Journal of China Pharmaceutical University, 2020, 51(4): 425-432. DOI: 10.11665/j.issn.1000-5048.20200406 |
[5] | TIAN Jiping, ZHANG Jian, ZHOU Jinpei, ZHANG Huibin. Advances in small molecule inhibitors of PD-1/PD-L1 immune checkpoint pathway[J]. Journal of China Pharmaceutical University, 2019, 50(1): 1-10. DOI: 10.11665/j.issn.1000-5048.20190101 |
[6] | LIU Kejun, ZHANG Zhimin, RAN Ting, CHEN Hongli, LU Tao, CHEN Yadong. Advances in BET bromodomain protein inhibitors[J]. Journal of China Pharmaceutical University, 2015, 46(3): 264-271. DOI: 10.11665/j.issn.1000-5048.20150302 |
[7] | ZHANG Yuan, CHENG Yulan, ZHOU Jinpei, ZHANG Huibin. Advances on receptor tyrosine kinase inhibitors taking c-Met as anti-tumor target[J]. Journal of China Pharmaceutical University, 2015, 46(1): 16-27. DOI: 10.11665/j.issn.1000-5048.20150102 |
[8] | LI Chunhong, DU Hongjin, WEN Xiao′an, SUN Hongbin. Advances in inhibitors of MDM2 and MDM4[J]. Journal of China Pharmaceutical University, 2015, 46(1): 1-15. DOI: 10.11665/j.issn.1000-5048.20150101 |
[9] | DENG Lian-bai, LI Ai-xiu, JIN Yu-rui. Advances in the study on inhibitors of RNase H,a novel anti-HIV drug target[J]. Journal of China Pharmaceutical University, 2011, 42(6): 578-584. |
[10] | KONG Kai-lai, LU Shuai, GAO Yi-ping, YANG Pei, TANG Wei-fang, LU Tao. Advances on the study of PLK1 inhibitors as antitumor agents[J]. Journal of China Pharmaceutical University, 2011, 42(1): 9-15. |
1. |
郁莉,蒋颖敏,许磊,朱景宇. 分子对接与分子动力学模拟法探究PI3Kδ/度维利塞(Duvelisib)的选择性结合. 化学研究与应用. 2022(02): 341-348 .
![]() | |
2. |
蔡燕飞,陈蕴,史劲松,金坚. 抗肿瘤药物体外药效学评价结合细胞生物学实验教学促进教研融合. 实验室研究与探索. 2020(08): 192-195 .
![]() |